<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25653435</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion.</ArticleTitle><Pagination><StartPage>4281</StartPage><EndPage>4295</EndPage><MedlinePgn>4281-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.03011-14</ELocationID><Abstract><AbstractText Label="UNLABELLED">The NS2A protein of dengue virus (DENV) has eight predicted transmembrane segments (pTMSs; pTMS1 to pTMS8). NS2A has been shown to participate in RNA replication, virion assembly, and the host antiviral response. However, the role of the amino acid residues within the pTMS regions of NS2A during the virus life cycle is poorly understood. In the study described here, we explored the function of DENV NS2A by introducing a series of double or triple alanine substitutions into the C-terminal half (pTMS4 to pTMS8) of NS2A in the context of a DENV infectious clone or subgenomic replicon. Fourteen (8 within pTMS8) of 35 NS2A mutants displayed a lethal phenotype due to impairment of RNA replication by a replicon assay. Three NS2A mutants with mutations within pTMS7, the CM20, CM25, and CM27 mutants, displayed similar phenotypes, low virus yields (&gt;100-fold reduction), wild-type-like replicon activity, and low infectious virus-like particle yields by transient trans-packaging experiments, suggesting a defect in virus assembly and secretion. The sequencing of revertant viruses derived from CM20, CM25, and CM27 mutant viruses revealed a consensus reversion mutation, leucine (L) to phenylalanine (F), at codon 181 within pTMS7. The introduction of an L181F mutation into a full-length NS2A mutant, i.e., the CM20, CM25, and CM27 constructs, completely restored wild-type infectivity. Notably, L181F also substantially rescued the other severely RNA replication-defective mutants with mutations within pTMS4, pTMS6, and pTMS8, i.e., the CM2, CM3, CM13, CM31, and CM32 mutants. In conclusion, the results revealed the essential roles of pTMS4 to pTMS8 of NS2A in RNA replication and/or virus assembly and secretion. The intramolecular interaction between pTMS7 and pTMS4, pTMS6, or pTMS8 of the NS2A protein was also implicated.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">The reported characterization of the C-terminal half of dengue virus NS2A is the first comprehensive mutagenesis study to investigate the function of flavivirus NS2A involved in the steps of the virus life cycle. In particular, detailed mapping of the amino acid residues within the predicted transmembrane segments (pTMSs) of NS2A involved in RNA replication and/or virus assembly and secretion was performed. A revertant genetics study also revealed that L181F within pTMS7 is a consensus reversion mutation that rescues both RNA replication-defective and virus assembly- and secretion-defective mutants with mutations within the other three pTMSs of NS2A. Collectively, these findings elucidate the role played by NS2A during the virus life cycle, possibly through the intricate intramolecular interaction between pTMS7 and other pTMSs within the NS2A protein.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ren-Huang</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ming-Han</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Day-Yu</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yueh</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli, Taiwan, Republic of China Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, Republic of China andrewyueh@nhri.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C079341">NS2A protein, Dengue virus type 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016296" MajorTopicYN="N">Mutagenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019065" MajorTopicYN="N">Virus Assembly</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25653435</ArticleId><ArticleId IdType="pmc">PMC4442377</ArticleId><ArticleId IdType="doi">10.1128/JVI.03011-14</ArticleId><ArticleId IdType="pii">JVI.03011-14</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lindenbach B, Murray C, Thiel H, Rice C. 2013. Flaviviridae. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed (electronic) Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Pierson TC, Diamond MS. 2013. Flaviviruses, p 747&#x2013;798. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 1 Lippincott Williams &amp; Wilkins, Philadelphia, PA.</Citation></Reference><Reference><Citation>Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. 2012. Dengue. N Engl J Med 366:1423&#x2013;1432. doi:10.1056/NEJMra1110265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1110265</ArticleId><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Kouri G. 2002. Dengue: an update. Lancet Infect Dis 2:33&#x2013;42. doi:10.1016/S1473-3099(01)00171-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(01)00171-2</ArticleId><ArticleId IdType="pubmed">11892494</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Kouri G. 2004. Dengue diagnosis, advances and challenges. Int J Infect Dis 8:69&#x2013;80. doi:10.1016/j.ijid.2003.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2003.03.003</ArticleId><ArticleId IdType="pubmed">14732325</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro FP, Corber SJ. 1997. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat Q 50:161&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">9477544</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ. 1989. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. Am J Trop Med Hyg 40:571&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">2472746</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. 1980. Dengue haemorrhagic fever&#x2014;a public health problem and a field for research. Bull World Health Organ 58:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395896</ArticleId><ArticleId IdType="pubmed">6966540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro FP. 1989. Dengue in the Americas. 1980-1987. Epidemiol Bull 10:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2484241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney RM, Butrapet S, Chang GJ, Tsuchiya KR, Roehrig JT, Bhamarapravati N, Gubler DJ. 1997. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230:300&#x2013;308. doi:10.1006/viro.1997.8500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8500</ArticleId><ArticleId IdType="pubmed">9143286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers TJ, Hahn CS, Galler R, Rice CM. 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649&#x2013;688. doi:10.1146/annurev.mi.44.100190.003245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003245</ArticleId><ArticleId IdType="pubmed">2174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Pethel M, Zhang YM, Lai CJ. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65:2467&#x2013;2475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240601</ArticleId><ArticleId IdType="pubmed">2016768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726&#x2013;733. doi:10.1126/science.4023707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.4023707</ArticleId><ArticleId IdType="pubmed">4023707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie JM, Khromykh AA, Jones MK, Westaway EG. 1998. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245:203&#x2013;215. doi:10.1006/viro.1998.9156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1998.9156</ArticleId><ArticleId IdType="pubmed">9636360</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. 2003. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333&#x2013;14338. doi:10.1073/pnas.2335168100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2335168100</ArticleId><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers TJ, McCourt DW, Rice CM. 1989. Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis. Virology 169:100&#x2013;109. doi:10.1016/0042-6822(89)90045-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(89)90045-7</ArticleId><ArticleId IdType="pubmed">2922923</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Gayen S, Kang C, Yuan Z, Shi PY. 2013. Membrane topology and function of dengue virus NS2A protein. J Virol 87:4609&#x2013;4622. doi:10.1128/JVI.02424-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02424-12</ArticleId><ArticleId IdType="pmc">PMC3624351</ArticleId><ArticleId IdType="pubmed">23408612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummerer BM, Rice CM. 2002. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol 76:4773&#x2013;4784. doi:10.1128/JVI.76.10.4773-4784.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.10.4773-4784.2002</ArticleId><ArticleId IdType="pmc">PMC136122</ArticleId><ArticleId IdType="pubmed">11967294</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JY, Pijlman GP, Kondratieva N, Hyde J, Mackenzie JM, Khromykh AA. 2008. Role of nonstructural protein NS2A in flavivirus assembly. J Virol 82:4731&#x2013;4741. doi:10.1128/JVI.00002-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00002-08</ArticleId><ArticleId IdType="pmc">PMC2346727</ArticleId><ArticleId IdType="pubmed">18337583</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Markoff L. 1995. Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol 69:7232&#x2013;7243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189645</ArticleId><ArticleId IdType="pubmed">7474145</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Zou J, Puttikhunt C, Yuan Z, Shi PY. 2015. Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly. J Virol 89:1298&#x2013;1313. doi:10.1128/JVI.02882-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02882-14</ArticleId><ArticleId IdType="pmc">PMC4300643</ArticleId><ArticleId IdType="pubmed">25392211</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WJ, Chen HB, Khromykh AA. 2003. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol 77:7804&#x2013;7813. doi:10.1128/JVI.77.14.7804-7813.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.14.7804-7813.2003</ArticleId><ArticleId IdType="pmc">PMC161959</ArticleId><ArticleId IdType="pubmed">12829820</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WJ, Chen HB, Wang XJ, Huang H, Khromykh AA. 2004. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78:12225&#x2013;12235. doi:10.1128/JVI.78.22.12225-12235.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.22.12225-12235.2004</ArticleId><ArticleId IdType="pmc">PMC525072</ArticleId><ArticleId IdType="pubmed">15507609</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA. 2006. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 80:2396&#x2013;2404. doi:10.1128/JVI.80.5.2396-2404.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.5.2396-2404.2006</ArticleId><ArticleId IdType="pmc">PMC1395377</ArticleId><ArticleId IdType="pubmed">16474146</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, Khromykh AA. 2005. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79:1934&#x2013;1942. doi:10.1128/JVI.79.3.1934-1942.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.3.1934-1942.2005</ArticleId><ArticleId IdType="pmc">PMC544092</ArticleId><ArticleId IdType="pubmed">15650219</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu YC, Yu CY, Liang JJ, Lin E, Liao CL, Lin YL. 2012. Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. J Virol 86:10347&#x2013;10358. doi:10.1128/JVI.00525-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00525-12</ArticleId><ArticleId IdType="pmc">PMC3457255</ArticleId><ArticleId IdType="pubmed">22787234</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YS, Liao CL, Tsao CH, Chen MC, Liu CI, Chen LK, Lin YL. 1999. Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J Virol 73:6257&#x2013;6264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112703</ArticleId><ArticleId IdType="pubmed">10400716</ArticleId></ArticleIdList></Reference><Reference><Citation>Melian EB, Edmonds JH, Nagasaki TK, Hinzman E, Floden N, Khromykh AA. 2013. West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response. J Gen Virol 94:308&#x2013;313. doi:10.1099/vir.0.047076-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.047076-0</ArticleId><ArticleId IdType="pmc">PMC3709616</ArticleId><ArticleId IdType="pubmed">23114626</ArticleId></ArticleIdList></Reference><Reference><Citation>Miroux B, Walker JE. 1996. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 260:289&#x2013;298. doi:10.1006/jmbi.1996.0399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1996.0399</ArticleId><ArticleId IdType="pubmed">8757792</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke D, Dawson D, Stearns T. 2000. Methods in yeast genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.</Citation></Reference><Reference><Citation>Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N. 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22:250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC268369</ArticleId><ArticleId IdType="pubmed">4031038</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu SY, Wu RH, Tsai MH, Yang CC, Chang CM, Yueh A. 2014. A novel approach to propagate flavivirus infectious cDNA clones in bacteria by introducing tandem repeat sequences upstream of virus genome. J Gen Virol 95:1493&#x2013;1503. doi:10.1099/vir.0.064915-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.064915-0</ArticleId><ArticleId IdType="pubmed">24728712</ArticleId></ArticleIdList></Reference><Reference><Citation>Blight KJ. 2011. Charged residues in hepatitis C virus NS4B are critical for multiple NS4B functions in RNA replication. J Virol 85:8158&#x2013;8171. doi:10.1128/JVI.00858-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00858-11</ArticleId><ArticleId IdType="pmc">PMC3147982</ArticleId><ArticleId IdType="pubmed">21680530</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul D, Romero-Brey I, Gouttenoire J, Stoitsova S, Krijnse-Locker J, Moradpour D, Bartenschlager R. 2011. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes. J Virol 85:6963&#x2013;6976. doi:10.1128/JVI.00502-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00502-11</ArticleId><ArticleId IdType="pmc">PMC3126587</ArticleId><ArticleId IdType="pubmed">21543474</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CC, Hsieh YC, Lee SJ, Wu SH, Liao CL, Tsao CH, Chao YS, Chern JH, Wu CP, Yueh A. 2011. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother 55:229&#x2013;238. doi:10.1128/AAC.00855-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00855-10</ArticleId><ArticleId IdType="pmc">PMC3019636</ArticleId><ArticleId IdType="pubmed">20937790</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CC, Tsai MH, Hu HS, Pu SY, Wu RH, Wu SH, Lin HM, Song JS, Chao YS, Yueh A. 2013. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Antiviral Res 98:228&#x2013;241. doi:10.1016/j.antiviral.2013.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.03.001</ArticleId><ArticleId IdType="pubmed">23499649</ArticleId></ArticleIdList></Reference><Reference><Citation>DiCiommo DP, Bremner R. 1998. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 273:18060&#x2013;18066. doi:10.1074/jbc.273.29.18060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.29.18060</ArticleId><ArticleId IdType="pubmed">9660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman BM, Summers PL, Dubois DR, Cohen WH, Gentry MK, Timchak RL, Burke DS, Eckels KH. 1989. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 41:576&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">2817214</ArticleId></ArticleIdList></Reference><Reference><Citation>Galula JU, Shen WF, Chuang ST, Chang GJ, Chao DY. 2014. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine. J Virol 88:10813&#x2013;10830. doi:10.1128/JVI.00810-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00810-14</ArticleId><ArticleId IdType="pmc">PMC4178884</ArticleId><ArticleId IdType="pubmed">25008922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi SL, Fayzulin R, Dewsbury N, Bourne N, Mason PW. 2007. Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo. Virology 364:184&#x2013;195. doi:10.1016/j.virol.2007.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.02.009</ArticleId><ArticleId IdType="pubmed">17382364</ArticleId></ArticleIdList></Reference><Reference><Citation>Haishi S, Tanaka M, Igarashi A. 1990. Comparative amino acid sequences of dengue viruses. Trop Med 32:81&#x2013;87.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>